After Interbrand successfully executed the rebranding initiative for Boehringer Ingelheim, a research-driven and family-owned biopharmaceutical company, one of the clinical trial teams within the company approached us for assistance in crafting a distinctive name and branding solution for their upcoming clinical trial. Working closely with a team of designers I developed an art direction and a minimalistic, modular layout system. To reflect the juxtaposition of the human-centric side of the trial with the innovative and scientific.
Client / Avenular Clincal Trial
Agency / Interbrand
Role / Art Director & Designer
